Synapticure, a telemedicine firm targeted on neurodegenerative illness, introduced it’s partnering with the ALS Affiliation to supply Synapticure’s telehealth platform as a complement to in-person care at ALS Licensed Therapy Facilities of Excellence and Acknowledged Therapy Facilities.
Synapticure is a neurology-focused telehealth firm that makes a speciality of neurodegenerative illnesses. It offers therapy for situations similar to Alzheimer’s, Parkinson’s and ALS. It gives companies that embrace psychological well being help, genetic testing and steering associated to scientific trials.
The partnership appears to deal with care inequities for individuals dwelling with ALS in geographically distant areas who typically lack entry to specialised care. An ALS Affiliation liaison will even be out there by means of Synapticure’s digital clinic to assist present personalised help to sufferers.
“Our mission at Synapticure is targeted on offering state-of-the-art care no matter geography. In partnership with the ALS Affiliation, harnessing our mixed nationwide attain and deep experience will allow us to revolutionize what it means to really serve the ALS inhabitants. Working collectively, we’ll set a brand new commonplace of digital care supply,” Sandra Abrevaya, CEO and cofounder of Synapticure, stated in an announcement.
THE LARGER TREND
Synapticure launched in February of 2022 with $6 million in seed funding led by GV, a enterprise capital funding arm of Alphabet. Further funding got here from LifeForce Capital, Martin Ventures, Y-Combinator and Byers Capital.
In September of 2023, the Chicago-based firm brought new CEO Joe Leinbach aboard. Leinbach was introduced on as the corporate continued to broaden neurodegenerative illness choices, which now embrace ones for Alzheimer’s and Dementia.
In December of 2023, ALS Affiliation partnered with digital pulmonary-care firm NuvoAir to launch a program tailor-made to individuals dwelling with ALS. The partnership launched with two clinics in Texas on the Texas Neurology Middle and College of Texas Well being Science Middle.
In February, ALS Affiliation acquired a $58 million donation from philanthropist Hugh Hoffman. The present is designated to advance ALS therapies and to develop new ALS clinics.
